Spots Global Cancer Trial Database for dexrazoxane hydrochloride

Every month we try and update this database with for dexrazoxane hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors	NCT00039481	Cardiac Toxicit... Unspecified Chi...	oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological...	1 Year - 21 Years	National Cancer Institute (NCI)
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma	NCT00742924	Sarcoma	cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna	- 40 Years	Children's Oncology Group
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma	NCT00003937	Cardiac Toxicit... Sarcoma	cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide methotrexate conventional su...	- 30 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma	NCT01230983	Cardiac Toxicit... Leukemia Lymphoma	asparaginase cytarabine dexrazoxane hyd... doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera...	- 21 Years	Children's Oncology Group
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer	NCT00016276	Cardiac Toxicit... Inflammatory Br... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast...	dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... paclitaxel trastuzumab therapeutic con... radiation thera... tamoxifen citra... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	NCT03589729	Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch...	Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin	12 Years -	M.D. Anderson Cancer Center
Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors	NCT00550901	Unspecified Adu...	cisplatin dexrazoxane hyd... high performanc... laboratory biom... mass spectromet... pharmacological...	18 Years -	City of Hope Medical Center
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)	NCT00098839	Recurrent Child...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... epratuzumab cytarabine prednisone pegaspargase dexrazoxane hyd... methotrexate etoposide cyclophosphamid... leucovorin calc... filgrastim	2 Years - 31 Years	Children's Oncology Group
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease	NCT00005578	Cardiac Toxicit... Lymphoma	bleomycin sulfa... filgrastim cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide prednisone vincristine sul... radiation thera...	- 21 Years	Children's Oncology Group
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma	NCT00742924	Sarcoma	cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna	- 40 Years	Children's Oncology Group
Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma	NCT01606878	Childhood Solid... Recurrent Child... Recurrent Neuro...	Crizotinib Cyclophosphamid... Dexrazoxane Hyd... Doxorubicin Hyd... Laboratory Biom... Pharmacological... Questionnaire A... Topotecan Hydro... Vincristine Sul...	13 Months - 21 Years	Children's Oncology Group
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	NCT03589729	Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch...	Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin	12 Years -	M.D. Anderson Cancer Center
Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors	NCT00039481	Cardiac Toxicit... Unspecified Chi...	oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological...	1 Year - 21 Years	National Cancer Institute (NCI)
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma	NCT00077285	Sarcoma	filgrastim carboplatin cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera...	- 50 Years	Memorial Sloan Kettering Cancer Center
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	NCT03589729	Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch...	Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin	12 Years -	M.D. Anderson Cancer Center
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease	NCT00002827	Cardiac Toxicit... Lymphoma	bleomycin sulfa... filgrastim dexrazoxane hyd... doxorubicin hyd... etoposide vincristine sul... low-LET cobalt-... low-LET electro... low-LET photon ...	- 21 Years	Children's Oncology Group
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	NCT03007147	Acute Lymphobla... B Acute Lymphob... Mixed Phenotype... T Acute Lymphob...	Allogeneic Hema... Calaspargase Pe... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Dexrazoxane Hyd... Doxorubicin Etoposide Filgrastim Ifosfamide Imatinib Mesyla... Laboratory Biom... Leucovorin Calc... Mercaptopurine Mercaptopurine Methotrexate Methylprednisol... Pegaspargase Prednisolone Questionnaire A... Therapeutic Hyd... Thioguanine Vincristine Sul...	1 Year - 21 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: